Literature DB >> 10889196

Vesicle-reconstituted low density lipoprotein receptor. Visualization by cryoelectron microscopy.

H Jeon1, G G Shipley.   

Abstract

The low density lipoprotein (LDL) receptor is a key protein for maintaining cellular cholesterol homeostasis by binding cholesterol-rich lipoproteins through their apoB and apoE apoproteins. The LDL receptor is a transmembrane glycoprotein of M(r) approximately 115 kDa; based on its primary sequence, five distinct structural domains have been identified (Yamamoto, T., Davis, C. G., Brown, M. S., Schneider, W. J., Casey, M. L., Goldstein, J. L., and Russell, D. W. (1984) Cell 39, 27-38). As a first step toward providing a structural description of the intact LDL receptor, the receptor has been purified from bovine adrenal cortices, reconstituted into unilamellar egg yolk phosphatidylcholine vesicles, and imaged using cryoelectron microscopy (cryoEM). CryoEM has the advantage of providing images of the reconstituted LDL receptor in its frozen, fully hydrated state. LDL receptor molecules were visualized as elongated, stick-like projections from the vesicle surface with maximum dimensions approximately 120-A length by approximately 45-A width. In some of the images, a short arm (or arms) was visible at the distal end of the stick-like projections. The LDL receptor was labeled via accessible free cysteine residues, probably including that corresponding to Cys-431 of the known full-length sequence of the human LDL receptor. The accessible cysteine was demonstrated using a maleimide-biotin.streptavidin conjugate and confirmed by labeling with monomaleimido-Nanogold. Images obtained by cryoEM showed that the extracellular stick-like domain of the reconstituted LDL receptor was labeled by Nanogold. This combined cryoEM-Nanogold labeling study has provided the first low resolution structural images of the reconstituted, full-length bovine LDL receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889196     DOI: 10.1074/jbc.M002583200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Role of an intramolecular contact on lipoprotein uptake by the LDL receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochim Biophys Acta       Date:  2011-04-09

2.  The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view.

Authors:  E A Hewat; E Neumann; J F Conway; R Moser; B Ronacher; T C Marlovits; D Blaas
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

3.  Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH.

Authors:  Paola Lo Surdo; Matthew J Bottomley; Alessandra Calzetta; Ethan C Settembre; Agostino Cirillo; Shilpa Pandit; Yan G Ni; Brian Hubbard; Ayesha Sitlani; Andrea Carfí
Journal:  EMBO Rep       Date:  2011-12-01       Impact factor: 8.807

4.  Site-specific biomolecule labeling with gold clusters.

Authors:  Christopher J Ackerson; Richard D Powell; James F Hainfeld
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

5.  The structure, dynamics, and binding of the LA45 module pair of the low-density lipoprotein receptor suggest an important role for LA4 in ligand release.

Authors:  Miklos Guttman; Elizabeth A Komives
Journal:  Biochemistry       Date:  2011-11-29       Impact factor: 3.162

6.  Conformational changes, plasma membrane penetration, and infection by human rhinovirus type 2: role of receptors and low pH.

Authors:  Marianne Brabec; Günther Baravalle; Dieter Blaas; Renate Fuchs
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  The role of calcium in lipoprotein release by the low-density lipoprotein receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

8.  Structural changes induced by acidic pH in human apolipoprotein B-100.

Authors:  José A Fernández-Higuero; Asier Benito-Vicente; Aitor Etxebarria; José Carlos G Milicua; Helena Ostolaza; José L R Arrondo; Cesar Martín
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

Review 9.  Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseases.

Authors:  Nicola Ferri
Journal:  Scientifica (Cairo)       Date:  2012-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.